RNA · Atrium Therapeutics, Inc.

NasdaqHealthcareBiotechnology

Atrium Therapeutics Inc Is A Biopharmaceutical Firm Focused On Developing Rna-Based Therapeutics For Cardiac Conditions, Including Cardiomyopathies. Its Platform Technology Is Designed To Enable Targeted Delivery Of Rna Therapeutics To Heart Tissue By Combining Ligand-Based Targeting Approaches With Oligonucleotide-Based Therapies. The Company'S Development Pipeline Includes Programs Targeting Genetically Associated Forms Of Cardiomyopathy, Specifically Involving The Prkag2 And Pln Genes.

HealthcareNasdaqUSMid Float

FLOAT

16.2M

FREE FLOAT %

95%

SHARES O/S

17.1M

MARKET CAP

$140.3M

EXCHANGE

Nasdaq

COUNTRY

RNA Catalyst History

No catalysts recorded for RNA yet

Day Trader Sniper hasn't classified a publishable catalyst for RNA yet. New events appear here as they're scored.

Be early on the next RNA spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

RNA · Atrium Therapeutics, Inc.

RNA Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.